tiprankstipranks
Trending News
More News >
Oruka Therapeutics reports Q4 EPS (49c), consensus (98c)
PremiumThe FlyOruka Therapeutics reports Q4 EPS (49c), consensus (98c)
1M ago
Oruka Therapeutics Positioned for Growth with Strategic Licensing and Promising IL-17A/F Inhibitor Development
Premium
Ratings
Oruka Therapeutics Positioned for Growth with Strategic Licensing and Promising IL-17A/F Inhibitor Development
2M ago
Oruka Therapeutics initiated with an Outperform at Wolfe Research
Premium
The Fly
Oruka Therapeutics initiated with an Outperform at Wolfe Research
2M ago
Oruka Therapeutics files to sell 8.72M shares of common stock for holders
PremiumThe FlyOruka Therapeutics files to sell 8.72M shares of common stock for holders
5M ago
Oruka Therapeutics reports Q3 EPS ($1.46), consensus (40c)
Premium
The Fly
Oruka Therapeutics reports Q3 EPS ($1.46), consensus (40c)
5M ago
Oruka Therapeutics initiated with a Buy at Stifel
Premium
The Fly
Oruka Therapeutics initiated with a Buy at Stifel
6M ago
Oruka Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe FlyOruka Therapeutics initiated with an Outperform at LifeSci Capital
7M ago
Oruka Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Oruka Therapeutics initiated with a Buy at TD Cowen
7M ago
Oruka Therapeutics Secures $200M to Advance Skin Disease Treatments
Premium
Company Announcements
Oruka Therapeutics Secures $200M to Advance Skin Disease Treatments
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100